Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology Psychedelic Drugs MDMA

New study suggests “comedowns” associated with MDMA are not a result of the drug itself

by Eric W. Dolan
April 22, 2022
in MDMA, Psychopharmacology
(Photo credit: DEA)

(Photo credit: DEA)

Share on TwitterShare on Facebook
Stay on top of the latest psychology findings: Subscribe now!

The drug MDMA (3,4-methylenedioxymethamphetamine) might not produce depressive “comedowns” when used in a controlled clinical setting, according to new research published in the Journal of Psychopharmacology. The findings offer some initial evidence that declines in mood and cognition in the days following MDMA use are produced by factors related to recreational consumption, such as drug impurity.

MDMA, commonly known as “molly,” has shown promise in treating various mental health conditions when combined with psychotherapeutic interventions. But there are concerns about the after-effects of the drug, which have been widely reported by recreational users.

“Decreased mood or ‘comedowns’ have been commonly noted amongst recreational MDMA users. We hypothesized that these comedowns might be more related to the context that individuals take recreational MDMA in rather than due to MDMA itself,” said study author Jacob Aday, a postdoctoral scholar in the Translational Psychedelic Research Program at University of California, San Francisco.

“In other words, when people take ‘MDMA’ recreationally, it is often cut with other drugs by suppliers and combined with alcohol and other substances by users, dosages are highly variable, and it is regularly taken in nightlife settings where dehydration, overheating, and lack of sleep may lead to impairments in cognition and mood in the following days. When given in a clinical context these confounding variables can be controlled.”

The researchers analyzed data collected from 8 men and 6 women diagnosed with alcohol use disorder who had completed an 8-week psychotherapy course that included 10 sessions. During two extended psychotherapy sessions, the participants received 125 mg of MDMA followed by another dose of 62.5 mg of MDMA two hours later. Following these two dosing sessions, the participants remained in the treatment center overnight.

Mood was assessed once a day for seven days after each MDMA session. The participants maintained a positive mood overall and the researchers observed no significant fluctuations. “Instead of a comedown, participants actually maintained a positive mood in the days after dosing,” Aday told PsyPost. In addition, the patients were asked open-ended questions on non-dosing days, such as “How do you feel about MDMA-assisted sessions,” and responses the questions were generally positive.

The study also assessed sleep quality at baseline, during a 3-month follow up, and during a 6-month follow up. The researchers found that sleep quality tended to improve following the psychotherapy sessions. This is in line with other research, which has indicated that MDMA-assisted psychotherapy is linked to sleep improvements.

The findings highlight “that the context drugs are taken in can play an important role in their risks,” Aday told PsyPost. “By using pure MDMA on a limited number of occasions, not combining it with other substances, getting proper nutrition, and taking it early enough in the day to still get adequate sleep, risks can be reduced — although not eliminated.”

But the researchers cautioned that the findings can only be considered preliminary at this point.

“There are several major caveats to keep in mind,” Aday explained. “The main being this was a small sample of 14 participants; however, we were mandated to use a small sample because these results were a part of an exploratory study of MDMA therapy for treating alcohol use disorder. The results were promising, so future studies with larger sample sizes are underway.”

“Additionally, because this was an exploratory study, it was open label with no control group, meaning participants knew they were going to get MDMA and not placebo. Because of this, we cannot rule expectation and placebo effects. Again, future research will build upon this work to address these questions.”

Even if MDMA does not produce transient declines in mood and cognition, the use of the substance still includes some risks. “Because MDMA raises heart rate and blood pressure while people are under the drug, those with heart conditions may be at increased risk for a cardiac event,” Aday said. “Additionally, individuals can be highly suggestible and vulnerable while under the influence of the drug, so it is important to take it in a safe context with trusted individuals.”

The study, “Debunking the myth of ‘Blue Mondays’: No evidence of affect drop after taking clinical MDMA“, was authored by Ben Sessa, Jacob S Aday, Steve O’Brien, H Valerie Curran, Fiona Measham, Laurie Higbed, and David J Nutt.

TweetSendScanShareSendPin2ShareShareShareShareShare

RELATED

Psychedelic use linked to increased risk of unusual visual experiences
Ayahuasca

Study links moderate awe in psychedelic ayahuasca journeys to better well-being

June 21, 2025

A new study published in the Journal of Psychoactive Drugs suggests that while awe can be transformative during ayahuasca retreats, there’s a limit. Experiences marked by excessive vastness were linked to lower well-being, challenging assumptions about awe’s universal benefits.

Read moreDetails
Cannabis intoxication alters metabolism, but frequent users show fewer effects
Cannabis

Regular cannabis use linked to changes in brain activity regulating movement

June 20, 2025

Researchers have discovered that frequent cannabis users show reduced spontaneous brain activity in the motor cortex, and this neural suppression is tied to cannabis use severity and response speed, even though overall task performance remained comparable to non-users.

Read moreDetails
About 8% of psychedelic users report inappropriate sexual contact by guides
Psychedelic Drugs

Study links psychedelic use in illegal settings to increased psychotic and manic symptoms

June 18, 2025

New research suggests that naturalistic psychedelic use may worsen psychotic and manic symptoms when used in illegal settings. People with schizophrenia or bipolar I disorder appeared especially vulnerable to these effects, highlighting the importance of context and psychiatric background.

Read moreDetails
Some dark personality traits may help buffer against depression, new psychology research suggests
Mental Health

Psilocybin-assisted therapy linked to reduced depression in people with bipolar disorder, small study finds

June 17, 2025

A pilot study involving psilocybin-assisted therapy found possible antidepressant effects for people with bipolar II disorder. The treatment appeared well-tolerated, with no signs of mania or psychosis, offering cautious optimism for future bipolar depression research.

Read moreDetails
Psilocybin from “magic” mushrooms weakens the brain’s response to angry faces
Addiction

Single-dose psilocybin therapy shows promise for reducing alcohol consumption

June 15, 2025

Early results from a pilot study indicate that psilocybin-assisted therapy could be linked to lower alcohol consumption and improved psychological outcomes, though larger controlled trials are needed to determine whether the psilocybin itself is responsible for these changes.

Read moreDetails
Psilocybin appears to have a uniquely powerful relationship with nature relatedness
Neuroimaging

Psilocybin induces large-scale brain network reorganization, offering insights into the psychedelic state

June 14, 2025

A new study using high-resolution EEG reveals that psilocybin dramatically alters brain connectivity in rats. The psychedelic induced dose-dependent changes in network organization, disrupting normal patterns of neural communication and suggesting rodents may be viable models for studying altered consciousness.

Read moreDetails
Poor sleep may shrink brain regions vulnerable to Alzheimer’s disease, study suggests
Addiction

Scientists map how alcohol changes bodily sensations

June 14, 2025

A new study suggests that people who feel fewer bodily sensations while intoxicated may be at higher risk for alcohol misuse. Using bodily maps and heartbeat tasks, researchers linked internal awareness to physiological effects and subjective feelings of intoxication.

Read moreDetails
Brain chemistry imbalance revealed in violent offenders with antisocial personality disorder
LSD

Flipping two atoms in LSD turned it into a powerful treatment for damaged brain circuits

June 13, 2025

A new study introduces JRT, a modified version of LSD that promotes brain cell growth without triggering hallucinations. Researchers say this non-hallucinogenic compound could offer safer treatment options for schizophrenia and related brain disorders where psychedelics are typically contraindicated.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

Exposure to heavy metals is associated with higher likelihood of ADHD diagnosis

Eye-tracking study shows people fixate longer on female aggressors than male ones

Romantic breakups follow a two-stage decline that begins years before the split, study finds

Believing “news will find me” is linked to sharing fake news, study finds

A common parasite not only invades the brain — it can also decapitate human sperm

Almost all unmarried pregant women say that the fetus resembles the father, study finds

New neuroscience research reveals brain antioxidant deficit in depression

Scientists uncover kidney-to-brain route for Parkinson’s-related protein spread

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy